NCT00858208 - Efficacy And Safety Of Macugen In Patients With Neovascular AMD In Routine Clinical Practice. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Neovascular Age-related Macular Degeneration

Interventions

DRUG

pegaptanib sodium

pegaptanib sodium intravitreal injection every 6 weeks for 2 years

Trial Locations (8)

Pfizer Investigational Site, Athens

Pfizer Investigational Site, Pátrai

Pfizer Investigational Site, Alexandroupoli

Pfizer Investigational Site, Athens

Pfizer Investigational Site, Larissa

Pfizer Investigational Site, Pátrai

Pfizer Investigational Site, Thessaloniki

Pfizer Investigational Site, Xánthi